Polaryx Therapeutics has activated the first clinical trial site at Boys Town National Research Hospital for its Phase 2 SOTERIA trial, testing PLX-200 in four rare pediatric lysosomal storage disorders. This milestone enables patient screening and advances the study toward initial dosing. The trial aims to assess safety and efficacy of PLX-200, which has FDA Fast Track status, with additional U.S. sites and European approvals expected in early 2027. Successful results could lead to expedited approval and new treatment options for these ultra-rare diseases.
Polaryx Therapeutics' clinical trial activation is the subject here, with Pluang's market data providing context. For readers following the health sector, 121 of 150 US health stocks rose while 18 fell. Notable movers include IBRX at USD 7.49 down 13.26%, ABEO at USD 3.65 down 12.47%, and IMVT at USD 33.50 up 9.73%. This snapshot is as of Nov 09, 2026 19:41 WIB.
The Software Safety Institute (SSI), a new independent nonprofit, has launched to tackle preventable harm caused by unsafe and insecure software. SSI aims to improve software safety by changing industry incentives and practices through research, publ...
Silvercrest Asset Management Group Inc. was ranked #8 in Nasdaq eVestment’s Q3 2026 Brand Awareness Rankings among mid-sized firms managing $2.5 billion to $40 billion in assets. This ranking reflects strong engagement from consultants and asset owne...
AST SpaceMobile is set to report its Q3 2026 earnings with an expected loss of $0.42 per share and revenue of $45.7 million. The company is advancing its satellite network technology, including a new joint venture with Rakuten to build a direct-to-de...
AnorTech Inc. completed a $7.55 million share exchange with Nasdaq-listed Greenland Mines, increasing Greenland Mines' ownership in AnorTech to 19.9%. Greenland Mines acquired over 25 million AnorTech shares in exchange for Greenland Mines shares val...
Neo Security, Inc. has launched Neoverse, a free AI software intelligence engine that researches and classifies over 4 million AI apps, extensions, and servers to assess their capabilities and security risks. Integrated into Neo's platform, Neoverse ...
